Oruch, R.; Rajab, H.A.; Elderbi, M.A.; Pryme, I.F.; Fasmer, O.B.; Lund, A.
Drawbacks of Olanzapine Therapy: An Emphasis on Its Metabolic Effects and Discontinuation. J. Clin. Med. 2025, 14, 8125.
https://doi.org/10.3390/jcm14228125
AMA Style
Oruch R, Rajab HA, Elderbi MA, Pryme IF, Fasmer OB, Lund A.
Drawbacks of Olanzapine Therapy: An Emphasis on Its Metabolic Effects and Discontinuation. Journal of Clinical Medicine. 2025; 14(22):8125.
https://doi.org/10.3390/jcm14228125
Chicago/Turabian Style
Oruch, Ramadhan, Hussein Abdullah Rajab, Mahmoud Abdalla Elderbi, Ian F. Pryme, Ole B. Fasmer, and Anders Lund.
2025. "Drawbacks of Olanzapine Therapy: An Emphasis on Its Metabolic Effects and Discontinuation" Journal of Clinical Medicine 14, no. 22: 8125.
https://doi.org/10.3390/jcm14228125
APA Style
Oruch, R., Rajab, H. A., Elderbi, M. A., Pryme, I. F., Fasmer, O. B., & Lund, A.
(2025). Drawbacks of Olanzapine Therapy: An Emphasis on Its Metabolic Effects and Discontinuation. Journal of Clinical Medicine, 14(22), 8125.
https://doi.org/10.3390/jcm14228125